• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体 φ29 编码蛋白 p56 的新型二聚体结构:对尿嘧啶-DNA 糖基化酶抑制作用的深入了解。

Novel dimeric structure of phage φ29-encoded protein p56: insights into uracil-DNA glycosylase inhibition.

机构信息

Departamento de Química Orgánica Biológica, Instituto de Química Orgánica General, CSIC, 28006 Madrid, Spain.

出版信息

Nucleic Acids Res. 2011 Dec;39(22):9779-88. doi: 10.1093/nar/gkr667. Epub 2011 Sep 2.

DOI:10.1093/nar/gkr667
PMID:21890898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3239192/
Abstract

Protein p56 encoded by the Bacillus subtilis phage φ29 inhibits the host uracil-DNA glycosylase (UDG) activity. To get insights into the structural basis for this inhibition, the NMR solution structure of p56 has been determined. The inhibitor defines a novel dimeric fold, stabilized by a combination of polar and extensive hydrophobic interactions. Each polypeptide chain contains three stretches of anti-parallel β-sheets and a helical region linked by three short loops. In addition, microcalorimetry titration experiments showed that it forms a tight 2:1 complex with UDG, strongly suggesting that the dimer represents the functional form of the inhibitor. This was further confirmed by the functional analysis of p56 mutants unable to assemble into dimers. We have also shown that the highly anionic region of the inhibitor plays a significant role in the inhibition of UDG. Thus, based on these findings and taking into account previous results that revealed similarities between the association mode of p56 and the phage PBS-1/PBS-2-encoded inhibitor Ugi with UDG, we propose that protein p56 might inhibit the enzyme by mimicking its DNA substrate.

摘要

由枯草芽孢杆菌噬菌体 φ29 编码的蛋白 p56 抑制宿主尿嘧啶-DNA 糖基化酶(UDG)活性。为了深入了解这种抑制的结构基础,已经确定了 p56 的 NMR 溶液结构。该抑制剂定义了一种新的二聚体折叠,由极性和广泛的疏水相互作用组合稳定。每个多肽链包含三个反平行 β-折叠区和一个螺旋区,由三个短环连接。此外,微量热滴定实验表明,它与 UDG 形成紧密的 2:1 复合物,强烈表明二聚体代表抑制剂的功能形式。这通过无法组装成二聚体的 p56 突变体的功能分析得到进一步证实。我们还表明,抑制剂的高度阴离子区域在抑制 UDG 中起着重要作用。因此,基于这些发现,并考虑到先前的结果表明 p56 的结合模式与噬菌体 PBS-1/PBS-2 编码的抑制剂 Ugi 与 UDG 之间存在相似性,我们提出蛋白 p56 可能通过模拟其 DNA 底物来抑制该酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/d26b44437dd1/gkr667f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/b9d387f583ab/gkr667f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/4571f4192b8b/gkr667f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/0a1fcd107e97/gkr667f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/25f495c157d4/gkr667f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/d26b44437dd1/gkr667f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/b9d387f583ab/gkr667f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/4571f4192b8b/gkr667f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/0a1fcd107e97/gkr667f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/25f495c157d4/gkr667f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8916/3239192/d26b44437dd1/gkr667f5.jpg

相似文献

1
Novel dimeric structure of phage φ29-encoded protein p56: insights into uracil-DNA glycosylase inhibition.噬菌体 φ29 编码蛋白 p56 的新型二聚体结构:对尿嘧啶-DNA 糖基化酶抑制作用的深入了解。
Nucleic Acids Res. 2011 Dec;39(22):9779-88. doi: 10.1093/nar/gkr667. Epub 2011 Sep 2.
2
Protein p56 from the Bacillus subtilis phage phi29 inhibits DNA-binding ability of uracil-DNA glycosylase.来自枯草芽孢杆菌噬菌体phi29的蛋白质p56抑制尿嘧啶-DNA糖基化酶的DNA结合能力。
Nucleic Acids Res. 2007;35(16):5393-401. doi: 10.1093/nar/gkm584. Epub 2007 Aug 13.
3
Characterization of Bacillus subtilis uracil-DNA glycosylase and its inhibition by phage φ29 protein p56.枯草芽孢杆菌尿嘧啶-DNA 糖基化酶的特性及其被噬菌体 φ29 蛋白 p56 的抑制。
Mol Microbiol. 2011 Jun;80(6):1657-66. doi: 10.1111/j.1365-2958.2011.07675.x. Epub 2011 May 12.
4
Crystal structure and functional insights into uracil-DNA glycosylase inhibition by phage Φ29 DNA mimic protein p56.噬菌体 Φ29 DNA 模拟蛋白 p56 对尿嘧啶-DNA 糖基化酶的抑制作用的晶体结构和功能见解。
Nucleic Acids Res. 2013 Jul;41(13):6761-73. doi: 10.1093/nar/gkt395. Epub 2013 May 13.
5
Architecturally diverse proteins converge on an analogous mechanism to inactivate Uracil-DNA glycosylase.结构多样的蛋白质汇聚到一种类似的机制,以失活尿嘧啶-DNA 糖基化酶。
Nucleic Acids Res. 2013 Oct;41(18):8760-75. doi: 10.1093/nar/gkt633. Epub 2013 Jul 26.
6
Phage phi29 protein p56 prevents viral DNA replication impairment caused by uracil excision activity of uracil-DNA glycosylase.噬菌体φ29蛋白p56可防止由尿嘧啶-DNA糖基化酶的尿嘧啶切除活性导致的病毒DNA复制损伤。
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19044-9. doi: 10.1073/pnas.0808797105. Epub 2008 Oct 9.
7
A uracil-DNA glycosylase inhibitor encoded by a non-uracil containing viral DNA.一种由不含尿嘧啶的病毒DNA编码的尿嘧啶-DNA糖基化酶抑制剂。
J Biol Chem. 2006 Mar 17;281(11):7068-74. doi: 10.1074/jbc.M511152200. Epub 2006 Jan 18.
8
Protein mimicry of DNA from crystal structures of the uracil-DNA glycosylase inhibitor protein and its complex with Escherichia coli uracil-DNA glycosylase.来自尿嘧啶-DNA糖基化酶抑制剂蛋白及其与大肠杆菌尿嘧啶-DNA糖基化酶复合物晶体结构的DNA蛋白质模拟
J Mol Biol. 1999 Mar 26;287(2):331-46. doi: 10.1006/jmbi.1999.2605.
9
Complexes of the uracil-DNA glycosylase inhibitor protein, Ugi, with Mycobacterium smegmatis and Mycobacterium tuberculosis uracil-DNA glycosylases.尿嘧啶-DNA糖基化酶抑制剂蛋白Ugi与耻垢分枝杆菌和结核分枝杆菌尿嘧啶-DNA糖基化酶的复合物。
Microbiology (Reading). 2003 Jul;149(Pt 7):1647-1658. doi: 10.1099/mic.0.26228-0.
10
X-ray analysis of a complex of Escherichia coli uracil DNA glycosylase (EcUDG) with a proteinaceous inhibitor. The structure elucidation of a prokaryotic UDG.大肠杆菌尿嘧啶DNA糖基化酶(EcUDG)与一种蛋白质抑制剂复合物的X射线分析。一种原核尿嘧啶DNA糖基化酶的结构解析。
Nucleic Acids Res. 1998 Nov 1;26(21):4880-7. doi: 10.1093/nar/26.21.4880.

引用本文的文献

1
Viruses with U-DNA: New Avenues for Biotechnology.具有 U-DNA 的病毒:生物技术的新途径。
Viruses. 2021 May 10;13(5):875. doi: 10.3390/v13050875.
2
DNA-Binding Proteins Essential for Protein-Primed Bacteriophage Φ29 DNA Replication.DNA 结合蛋白对于噬菌体 Φ29 蛋白引发的 DNA 复制是必需的。
Front Mol Biosci. 2016 Aug 5;3:37. doi: 10.3389/fmolb.2016.00037. eCollection 2016.
3
Using structural-based protein engineering to modulate the differential inhibition effects of SAUGI on human and HSV uracil DNA glycosylase.利用基于结构的蛋白质工程来调节SAUGI对人源和单纯疱疹病毒尿嘧啶DNA糖基化酶的差异抑制作用。

本文引用的文献

1
Characterization of Bacillus subtilis uracil-DNA glycosylase and its inhibition by phage φ29 protein p56.枯草芽孢杆菌尿嘧啶-DNA 糖基化酶的特性及其被噬菌体 φ29 蛋白 p56 的抑制。
Mol Microbiol. 2011 Jun;80(6):1657-66. doi: 10.1111/j.1365-2958.2011.07675.x. Epub 2011 May 12.
2
A mutational analysis of DNA mimicry by ocr, the gene 0.3 antirestriction protein of bacteriophage T7.噬菌体T7的基因0.3抗限制蛋白ocr对DNA模拟的突变分析。
Biochem Biophys Res Commun. 2009 Jan 2;378(1):129-32. doi: 10.1016/j.bbrc.2008.11.014. Epub 2008 Nov 21.
3
Phage phi29 protein p56 prevents viral DNA replication impairment caused by uracil excision activity of uracil-DNA glycosylase.
Nucleic Acids Res. 2016 May 19;44(9):4440-9. doi: 10.1093/nar/gkw185. Epub 2016 Mar 14.
4
Staphylococcus aureus protein SAUGI acts as a uracil-DNA glycosylase inhibitor.金黄色葡萄球菌蛋白 SAUGI 作为尿嘧啶-DNA 糖基化酶抑制剂。
Nucleic Acids Res. 2014 Jan;42(2):1354-64. doi: 10.1093/nar/gkt964. Epub 2013 Oct 22.
5
Architecturally diverse proteins converge on an analogous mechanism to inactivate Uracil-DNA glycosylase.结构多样的蛋白质汇聚到一种类似的机制,以失活尿嘧啶-DNA 糖基化酶。
Nucleic Acids Res. 2013 Oct;41(18):8760-75. doi: 10.1093/nar/gkt633. Epub 2013 Jul 26.
6
Crystal structure and functional insights into uracil-DNA glycosylase inhibition by phage Φ29 DNA mimic protein p56.噬菌体 Φ29 DNA 模拟蛋白 p56 对尿嘧啶-DNA 糖基化酶的抑制作用的晶体结构和功能见解。
Nucleic Acids Res. 2013 Jul;41(13):6761-73. doi: 10.1093/nar/gkt395. Epub 2013 May 13.
噬菌体φ29蛋白p56可防止由尿嘧啶-DNA糖基化酶的尿嘧啶切除活性导致的病毒DNA复制损伤。
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19044-9. doi: 10.1073/pnas.0808797105. Epub 2008 Oct 9.
4
Protein p56 from the Bacillus subtilis phage phi29 inhibits DNA-binding ability of uracil-DNA glycosylase.来自枯草芽孢杆菌噬菌体phi29的蛋白质p56抑制尿嘧啶-DNA糖基化酶的DNA结合能力。
Nucleic Acids Res. 2007;35(16):5393-401. doi: 10.1093/nar/gkm584. Epub 2007 Aug 13.
5
Uracil in DNA--general mutagen, but normal intermediate in acquired immunity.DNA中的尿嘧啶——一般诱变剂,但在获得性免疫中是正常中间体。
DNA Repair (Amst). 2007 Apr 1;6(4):505-16. doi: 10.1016/j.dnarep.2006.10.014. Epub 2006 Nov 20.
6
A uracil-DNA glycosylase inhibitor encoded by a non-uracil containing viral DNA.一种由不含尿嘧啶的病毒DNA编码的尿嘧啶-DNA糖基化酶抑制剂。
J Biol Chem. 2006 Mar 17;281(11):7068-74. doi: 10.1074/jbc.M511152200. Epub 2006 Jan 18.
7
Uracil-directed ligand tethering: an efficient strategy for uracil DNA glycosylase (UNG) inhibitor development.尿嘧啶导向的配体连接:一种开发尿嘧啶DNA糖基化酶(UNG)抑制剂的有效策略。
J Am Chem Soc. 2005 Dec 14;127(49):17412-20. doi: 10.1021/ja055846n.
8
Uracil in DNA--occurrence, consequences and repair.DNA中的尿嘧啶——存在、后果及修复
Oncogene. 2002 Dec 16;21(58):8935-48. doi: 10.1038/sj.onc.1205996.
9
Roles of uracil-DNA glycosylase and dUTPase in virus replication.尿嘧啶-DNA糖基化酶和dUTPase在病毒复制中的作用。
J Gen Virol. 2002 Oct;83(Pt 10):2339-2345. doi: 10.1099/0022-1317-83-10-2339.
10
Characterisation of the structure of ocr, the gene 0.3 protein of bacteriophage T7.噬菌体T7的基因0.3蛋白ocr的结构表征。
Nucleic Acids Res. 2001 Jul 15;29(14):3059-68. doi: 10.1093/nar/29.14.3059.